See every side of every news story
Published loading...Updated

Vivace Therapeutics Raises $35M in Series D Financing

Summary by FinSMEs
Vivace Therapeutics, a San Mateo, CA-based small molecule discovery and development company, raised $35M in Series D funding. The round was led by RA Capital Management, an existing investor, and included investment from other existing investors Canaan Partners and Cenova Capital. In conjunction with the financing, Jake Simson, Ph.D., partner at RA Capital Management, has joined […] The post Vivace Therapeutics Raises $35M in Series D Financing …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

FinSMEs broke the news in on Wednesday, March 12, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.